Most protocols for screening and diagnosis are initiated at 24–28 gestational weeks, and previously studies have demonstrated a number of serum markers (e.g. sex hormone-binding globulin, the homeostasis model assessment index and C-reactive protein) measured in the first and early second trimesters are associated with the later diagnosis of GDM [20], [21], [22], [23]. Here, CRP is linked to gestational diabetes.